RAD 202 receives approval to start Phase 1 therapeutic trial
Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on investingnews.com
Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on investingnews.com
The fate of President Joe Biden’s landmark climate legislation, the Inflation Reduction Act, is in the hands of the incoming Republican-controlled White House, Senate and House of Representatives. At the White…
Malls used to be the destination for the buzziest stores. Now they’re home to the hottest restaurants. The slow death of department stores and rise of online shopping have hurt…
When athleisure brand Vuori launched in 2015, it was headquartered in a garage, sold only men’s shorts and couldn’t get investors to give it the time of day. Now, the…
With one month left in office, President Biden’s approval rating is hitting a new low. Biden stands at 34% approval and 66% disapproval in a Marquette Law School national poll…
Robert F. Kennedy Jr. has been on Capitol Hill this week in an attempt to drum up support for his nomination to be the next leader of the Department of…
Sen. John Fetterman, D-Pa., has suggested that it is his duty to meet with President-elect Donald Trump’s nominees, noting that his decision about whether to vote to confirm the candidates…
The Senate voted to pass the $895 billion annual defense policy bill that includes a pay raise for U.S. servicemembers and a provision that restricts transgender care. The bill passed…
While the S&P 500 and Nasdaq 100 have been holding steady into this week’s Fed meeting, warning signs under the hood have suggested one of two things is likely to…
The uranium market entered 2024 on strong footing after a year of significant price movement, as well as renewed attention on nuclear energy’s role in the global energy transition. After…